Your browser doesn't support javascript.
loading
AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial.
Kosalaraksa, Pope; Jeanfreau, Robert; Frenette, Louise; Drame, Mamadou; Madariaga, Miguel; Innis, Bruce L; Godeaux, Olivier; Izurieta, Patricia; Vaughn, David W.
Affiliation
  • Kosalaraksa P; Department of Pediatrics, Khon Kaen University, Thailand.
  • Jeanfreau R; Internal Medicine, Benchmark Research, Metairie, Louisiana.
  • Frenette L; QT Research, Sherbrooke, Canada.
  • Drame M; GlaxoSmithKline Vaccines, King of Prussia, Pennsylvania.
  • Madariaga M; GlaxoSmithKline Vaccines, King of Prussia, Pennsylvania.
  • Innis BL; GlaxoSmithKline Vaccines, King of Prussia, Pennsylvania.
  • Godeaux O; GlaxoSmithKline Vaccines, Wavre.
  • Izurieta P; GlaxoSmithKline Vaccines, Wavre.
  • Vaughn DW; GlaxoSmithKline Vaccines, Rixensart, Belgium.
J Infect Dis ; 211(5): 801-10, 2015 Mar 01.
Article in En | MEDLINE | ID: mdl-25293368
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Polysorbates / Squalene / Influenza Vaccines / Adjuvants, Immunologic / Alpha-Tocopherol / Influenza, Human / Influenza A Virus, H5N1 Subtype Type of study: Clinical_trials / Prognostic_studies Language: En Journal: J Infect Dis Year: 2015 Type: Article Affiliation country: Thailand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Polysorbates / Squalene / Influenza Vaccines / Adjuvants, Immunologic / Alpha-Tocopherol / Influenza, Human / Influenza A Virus, H5N1 Subtype Type of study: Clinical_trials / Prognostic_studies Language: En Journal: J Infect Dis Year: 2015 Type: Article Affiliation country: Thailand